---
figid: PMC9366225__gr1
figtitle: CXCR6-based immunotherapy in autoimmune, cancer and inflammatory infliction
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC9366225
filename: gr1.jpg
figlink: /pmc/articles/PMC9366225/figure/fig1/
number: F1
caption: The function of CXCR6 and CXCL16. The left panel shows the process of CXCR6+
  cell differentiation, adhesion, infiltration and recruiting to the inflamed or tumor
  site and interacting with DC or tissue cells with CXCR6 expression. The right panel
  exhibits the activated intracellular signaling pathway upon CXCR6–CXCL16 binding.
  IL, interleukin; CXCL16, CXC chemokine ligand 16; mCXCL16, transmembrane CXCL16;
  sCXCL16, soluble form of CXCL16; IFN, interferon; TNF, tumor necrosis factor; PRF,
  perforin; Gzm, granzyme; ADAM10, metalloproteinase 10; DC, dendritic cell; CXCR6,
  CXC chemokine receptor 6; Akt/mTOR, protein-serine-threonine kinase/mammalian target
  of rapamycin; ERK/MAPK, extracellular regulated protein kinases/mitogen-activated
  protein kinases; NF-κB, nuclear factor kappa-B.
papertitle: CXCR6-based immunotherapy in autoimmune, cancer and inflammatory infliction.
reftext: Tingting Li, et al. Acta Pharm Sin B. 2022 Aug;12(8):3255-3262.
year: '2022'
doi: 10.1016/j.apsb.2022.03.012
journal_title: Acta Pharmaceutica Sinica. B
journal_nlm_ta: Acta Pharm Sin B
publisher_name: Elsevier
keywords: CXCR6 | CXCL16 | Inflammation | Autoimmune diseases | Tumor | Immunotherapy
  | Nonalcoholic steatohepatitis | COVID-19
automl_pathway: 0.9474745
figid_alias: PMC9366225__F1
figtype: Figure
redirect_from: /figures/PMC9366225__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9366225__gr1.html
  '@type': Dataset
  description: The function of CXCR6 and CXCL16. The left panel shows the process
    of CXCR6+ cell differentiation, adhesion, infiltration and recruiting to the inflamed
    or tumor site and interacting with DC or tissue cells with CXCR6 expression. The
    right panel exhibits the activated intracellular signaling pathway upon CXCR6–CXCL16
    binding. IL, interleukin; CXCL16, CXC chemokine ligand 16; mCXCL16, transmembrane
    CXCL16; sCXCL16, soluble form of CXCL16; IFN, interferon; TNF, tumor necrosis
    factor; PRF, perforin; Gzm, granzyme; ADAM10, metalloproteinase 10; DC, dendritic
    cell; CXCR6, CXC chemokine receptor 6; Akt/mTOR, protein-serine-threonine kinase/mammalian
    target of rapamycin; ERK/MAPK, extracellular regulated protein kinases/mitogen-activated
    protein kinases; NF-κB, nuclear factor kappa-B.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - egr
  - kuz
  - Kul
  - dc
  - Akt
  - Mtor
  - Tor
  - Dif
  - dl
  - Rel
  - MKP-4
  - p38b
  - rl
  - Erk7
  - IL15
  - IL2
  - IL12A
  - IL12B
  - TNF
  - ADAM10
  - IL17A
  - PFN1
  - PFN2
  - PFN3
  - PFN4
  - AKT1
  - AKT2
  - AKT3
  - MTOR
  - NFKB1
  - CXCR6
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - EPHB2
---
